Total Payments
$56,955
2024 Payments
$101.09
Companies
9
Transactions
56
Medicare Patients
518
Medicare Billing
$80,090
Payment Breakdown by Category
Other$32,940 (57.8%)
Consulting$19,795 (34.8%)
Travel$2,779 (4.9%)
Food & Beverage$1,441 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,336 | 12 | 39.2% |
| Consulting Fee | $19,795 | 7 | 34.8% |
| Honoraria | $10,604 | 5 | 18.6% |
| Travel and Lodging | $2,779 | 11 | 4.9% |
| Food and Beverage | $1,441 | 21 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18,129 | 17 | $0 (2021) |
| Blueprint Medicines Corporation | $10,891 | 9 | $0 (2024) |
| Taiho Oncology, Inc. | $9,466 | 7 | $0 (2020) |
| GlaxoSmithKline, LLC. | $6,500 | 1 | $0 (2023) |
| Incyte Corporation | $6,147 | 14 | $0 (2017) |
| CTI BioPharma Corp. | $3,080 | 1 | $0 (2023) |
| Celgene Corporation | $2,050 | 5 | $0 (2019) |
| ABBVIE INC. | $675.00 | 1 | $0 (2023) |
| Spectrum Pharmaceuticals Inc. | $18.32 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $101.09 | 1 | Blueprint Medicines Corporation ($101.09) |
| 2023 | $10,255 | 3 | GlaxoSmithKline, LLC. ($6,500) |
| 2022 | $5,361 | 3 | Blueprint Medicines Corporation ($5,361) |
| 2021 | $5,924 | 5 | Blueprint Medicines Corporation ($3,449) |
| 2020 | $17,981 | 15 | Taiho Oncology, Inc. ($9,466) |
| 2019 | $8,868 | 9 | Novartis Pharmaceuticals Corporation ($8,772) |
| 2018 | $1,886 | 3 | Celgene Corporation ($1,886) |
| 2017 | $6,579 | 17 | Incyte Corporation ($6,147) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $101.09 | General |
| Category: Oncology / Rare Diseases | ||||||
| 08/24/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Consulting Fee | Cash or cash equivalent | $3,080.00 | General |
| Category: Hematology | ||||||
| 07/07/2023 | ABBVIE INC. | VENCLEXTA (Drug) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $6,500.00 | General |
| 04/06/2022 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Honoraria | Cash or cash equivalent | $4,004.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 03/31/2022 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: Oncology / Rare Diseases | ||||||
| 02/02/2022 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Honoraria | Cash or cash equivalent | $1,232.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/16/2021 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Honoraria | Cash or cash equivalent | $2,156.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/10/2021 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $43.47 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/10/2021 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/03/2021 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Honoraria | Cash or cash equivalent | $1,232.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 03/19/2021 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $2,475.00 | General |
| 12/04/2020 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Honoraria | Cash or cash equivalent | $1,980.00 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/23/2020 | Taiho Oncology, Inc. | INQOVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,565.00 | General |
| Category: Hematology | ||||||
| 10/13/2020 | Taiho Oncology, Inc. | INQOVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,565.00 | General |
| Category: Hematology | ||||||
| 10/12/2020 | Taiho Oncology, Inc. | INQOVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $391.25 | General |
| Category: Hematology | ||||||
| 10/06/2020 | Taiho Oncology, Inc. | INQOVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,565.00 | General |
| Category: Hematology | ||||||
| 10/01/2020 | Taiho Oncology, Inc. | INQOVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,565.00 | General |
| Category: Hematology | ||||||
| 09/11/2020 | Novartis Pharmaceuticals Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,475.00 | General |
| 09/08/2020 | Taiho Oncology, Inc. | INQOVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,565.00 | General |
| Category: Hematology | ||||||
| 09/03/2020 | Taiho Oncology, Inc. | INQOVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Hematology | ||||||
| 03/05/2020 | Novartis Pharmaceuticals Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,970.00 | General |
| 03/05/2020 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $402.70 | General |
| 03/05/2020 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | Cash or cash equivalent | $342.18 | General |
| 03/05/2020 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $215.86 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 125 | 238 | $45,318 | $18,781 |
| 2022 | 3 | 116 | 248 | $43,824 | $18,569 |
| 2021 | 3 | 127 | 320 | $52,576 | $23,856 |
| 2020 | 3 | 150 | 227 | $45,623 | $18,884 |
Total Patients
518
Total Services
1,033
Medicare Billing
$80,090
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 82 | 141 | $25,000 | $10,449 | 41.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 30 | 30 | $10,270 | $4,336 | 42.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 67 | $10,048 | $3,996 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 74 | 134 | $22,652 | $9,853 | 43.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 90 | $13,320 | $5,165 | 38.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 24 | 24 | $7,852 | $3,552 | 45.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 84 | 172 | $26,601 | $13,428 | 50.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 125 | $18,500 | $7,028 | 38.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 23 | 23 | $7,475 | $3,400 | 45.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 58 | 98 | $21,070 | $8,356 | 39.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 64 | 101 | $15,453 | $6,596 | 42.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 28 | 28 | $9,100 | $3,931 | 43.2% |
About Dr. Eric Padron, M.D
Dr. Eric Padron, M.D is a Internal Medicine healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003904889.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Padron, M.D has received a total of $56,955 in payments from pharmaceutical and medical device companies, with $101.09 received in 2024. These payments were reported across 56 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($22,336).
As a Medicare-enrolled provider, Padron has provided services to 518 Medicare beneficiaries, totaling 1,033 services with total Medicare billing of $80,090. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Medical Oncology
- Location Tampa, FL
- Active Since 10/10/2006
- Last Updated 03/05/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003904889
Products in Payments
- AYVAKIT (Drug) $10,891
- INQOVI (Drug) $9,466
- JAKAFI (Drug) $6,147
- RYDAPT (Drug) $5,567
- Vonjo (Drug) $3,080
- VENCLEXTA (Drug) $675.00
- PROMACTA (Drug) $605.49
- Vidaza (Drug) $104.96
- Folotyn (Drug) $18.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tampa
Javier Pinilla-Ibarz, Md, MD
Internal Medicine — Payments: $1.9M
Internal Medicine $1.9M
Alberto Chiappori, Md, MD
Internal Medicine — Payments: $617,120
Internal Medicine $617,120
Ricardo Restrepo-Jaramillo, M.d, M.D
Internal Medicine — Payments: $562,511
Internal Medicine $562,511
Dr. Sady Alpizar, Md, MD
Internal Medicine — Payments: $509,824
Internal Medicine $509,824
Jhanelle Gray, Md, MD
Internal Medicine — Payments: $273,892
Internal Medicine $273,892
Dr. Andrew Kuykendall, M.d, M.D
Internal Medicine — Payments: $273,357
Internal Medicine $273,357